Abstract
The immaturity of pluripotent stem cell (PSC)-derived tissues has emerged as a universal problem for their biomedical applications. While efforts have been made to generate adult-like cells from PSCs, direct benchmarking of PSC-derived tissues against in vivo development has not been established. Thus, maturation status is often assessed on an ad-hoc basis. Single cell RNA-sequencing (scRNA-seq) offers a promising solution, though cross-study comparison is limited by dataset-specific batch effects. Here, we developed a novel approach to quantify PSC-derived cardiomyocyte (CM) maturation through transcriptomic entropy. Transcriptomic entropy is robust across datasets regardless of differences in isolation protocols, library preparation, and other potential batch effects. With this new model, we analyzed over 45 scRNA-seq datasets and over 52,000 CMs, and established a cross-study, cross-species CM maturation reference. This reference enabled us to directly compare PSC-CMs with the in vivo developmental trajectory and thereby to quantify PSC-CM maturation status. We further found that our entropy-based approach can be used for other cell types, including pancreatic beta cells and hepatocytes. Our study presents a biologically relevant and interpretable metric for quantifying PSC-derived tissue maturation, and is extensible to numerous tissue engineering contexts.
Funder
American Heart Association
TEDCO/Maryland stem cell research fund
National Institutes of Health/NHLBI
Publisher
Public Library of Science (PLoS)
Subject
Computational Theory and Mathematics,Cellular and Molecular Neuroscience,Genetics,Molecular Biology,Ecology,Modeling and Simulation,Ecology, Evolution, Behavior and Systematics
Reference63 articles.
1. Drug screening for human genetic diseases using iPSC models;MS Elitt;Hum Mol Genet,2018
2. Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform;AD Ebert;J Cardiovasc Pharmacol,2012
3. Induced pluripotent stem cells in disease modelling and drug discovery;RG Rowe;Nat Rev Genet,2019
4. Human pluripotent stem cells in regenerative medicine: where do we stand?;HT Nguyen;Reproduction,2015
5. Induced Pluripotent Stem Cells for Regenerative Medicine.;KK Hirschi;Annu Rev Biomed Eng,2014
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献